Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/12029
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaleh, Arman Yurisaldi-
dc.contributor.authorSaputra, Dwi Arwandi Yogi-
dc.contributor.authorValentina, Riezky-
dc.contributor.authorSusanto, Tirta Darmawan-
dc.date.accessioned2025-07-17T02:58:02Z-
dc.date.available2025-07-17T02:58:02Z-
dc.date.issued2025-
dc.identifier.issn0975-3575-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/12029-
dc.description.abstractIntroduction: With its anti-inflammatory and antioxidant capabilities, Moringa oleifera is gaining interest for its neuroprotective potential. This bibliometric analysis examines Moringa oleifera research trends, gaps, and future prospects, focusing on its function in cognitive deficits and neurodegenerative disorders like Alzheimer's. Topiramate and riluzole's neuroprotective effects are also discussed.; Materials and methods: Research trends in Moringa oleifera were examined using Scopus-indexed literature. The plant parts studied (leaves, seeds, roots), doses, and methods were key. The review included antiepileptic medication trials to complement their neuroprotective properties. Results and discussion: Antioxidant and phytochemical properties made Moringa oleifera a promising neuroprotectant, according to the review. However, dose reporting and plant part specification variations compromised findings' reliability and reproducibility. To maintain methodological consistency, dose-response studies, uniform reporting techniques, and interdisciplinary collaboration are future research topics. Antiepileptic medications like topiramate and riluzole modulate neurotransmitter systems and provide neuroprotection with natural products. Conclusions: This analysis emphasizes the necessity for rigorous research and standardized methods to enhance Moringa oleifera and related pharmacological compounds' therapeutic potential. Addressing these obstacles will improve findings' reliability and clinical application, enabling evidencebased neurological condition treatments. This research was conducted in January 2025.en_US
dc.language.isoen_USen_US
dc.publisherPharmacognosy Journalen_US
dc.relation.ispartofseriesReview Article;258-276-
dc.subjectMoringa Oleiferaen_US
dc.subjectNeuroprotectiveen_US
dc.subjectBrainen_US
dc.subjectTherapyen_US
dc.subjectHerben_US
dc.subjectNatural Agenten_US
dc.titleThe Miracle Moringa Oleifera Tree: A Bibliometric Review of Its Neuroprotective Propertiesen_US
dc.typeArticleen_US
Appears in Collections:VOL 17 NO. 2 (2025)

Files in This Item:
File Description SizeFormat 
258-276.pdf1.32 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.